ArticleTranslational cancer research2019

Pooled analysis of the clinical benefit of cyclooxygenase-2 inhibitors combined with chemotherapy in advanced non-small cell lung cancer.

Wei Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.